BlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior Advisors

NEW YORK–(BUSINESS WIRE)–BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former U.S. Senator Joe Manchin has joined the company as a Senior Advisor. BlinkRx also announced that Heather Manchin, a seasoned healthcare executive and former CEO of Mylan, will serve alongside him as a Senior Advisor.


Senator Manchin brings decades of bipartisan experience navigating complex policy challenges at the intersection of healthcare, economics, and public accountability. Known for his pragmatic approach and willingness to work across party lines, Manchin has long focused on advancing solutions that deliver real-world benefits for American families, particularly in areas where the system has failed to keep costs down or outcomes up.

Heather Manchin adds deep operational and leadership experience from the private sector, including serving as CEO of Mylan, one of the world’s largest pharmaceutical companies. Her career has focused on confronting structural failures in healthcare markets, from pricing and access to regulatory complexity, as well as advocating for solutions that restore competition, transparency, and patient agency. She currently serves on the Board of the USC Schaeffer Center for Health Policy & Economics and is the founder of Americans Together.

Senator Manchin and Heather Manchin, who together make up the strategic advisory firm Manchin Partners, bring a rare combination of public policy insight and hands-on healthcare industry leadership that will support BlinkRx as it continues to radically modernize the prescription drug ecosystem.

“I’m pleased to join BlinkRx and support work that brings people together around practical solutions to our healthcare challenges,” said Senator Manchin. “No matter where you come from or what party you belong to, everyone agrees that patients deserve affordable medications and a system that works better. BlinkRx is focused on common-sense improvements that increase transparency, reduce unnecessary barriers, and help patients get the care they need, and I look forward to contributing to that effort.”

“Much of my career has been spent confronting how opaque systems distort pricing and limit access for patients,” said Heather Manchin. “BlinkRx represents the kind of private-market innovation healthcare has been missing and is the first market solution that is well-positioned to solve the access and affordability issue for patients and the industry.”

“After hearing Senator Manchin on the All-In Podcast and then meeting Heather, it was immediately clear that this was a team we wanted to work with,” said Matt Chaiken, Co-Founder and President of BlinkRx. “Senator Manchin’s deep bipartisan policy experience and Heather’s insight into how medicines are developed, distributed, and accessed will be incredibly valuable as we scale and continue building solutions that work for patients, providers, and pharmacies alike.”

“Senator Manchin understands how to take on hard problems and get results, especially in environments where progress requires trust, persistence, and practical thinking,” said Geoff Chaiken, Co-Founder and CEO of BlinkRx. “We’re honored to have him advising BlinkRx as we work to make the prescription drug system more transparent, competitive, and patient-first. Equally important, Heather Manchin brings firsthand experience leading a global pharmaceutical company and navigating the operational realities of healthcare.”

Senator Manchin and Heather Manchin, through Manchin Partners, will provide strategic counsel to BlinkRx’s leadership team as the company expands its platform and deepens its efforts to reduce costs, increase access, and simplify how patients receive the medications they need.

About BlinkRx

BlinkRx is redefining the pharmacy experience with integrated data-driven technology that improves patient access to branded medications. Its prescription journey management platform streamlines every step of the process, removing friction for all stakeholders. Patients enjoy the lowest possible pricing, free home delivery, and personalized support. Healthcare providers benefit from dedicated access teams and enhanced prior authorization support for their patients. Pharmacies have fewer administrative burdens. And pharmaceutical manufacturers gain total transparency from prescription to fulfillment. Learn more at www.blinkrx.com.

Contacts

For media inquiries, please contact: [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.